GlobeNewsWire
23 Sept 2026, 11:45 UTC · 4h ago
Verdict
Headline leans bullish. We score CAPR −1.00 across three claims.
Score contradicts the headline.
Leans bullish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
The FDA released briefing documents on July 27, 2026, stating that Capricor's final statistical analysis plan for the Dermamiocel BLA was not submitted to or agreed upon by the FDA.
Priced inoccurred July 27, 2026; article published Sept 23
More negative than 95% of claims this week
Capricor's stock price dropped $12.70, or 64%, to close at $7 per share on July 27, 2026.
Priced in
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
So whatThe 64% valuation haircut reflects a massive loss in market cap that may trigger debt covenants or limit future equity financing.
More negative than 79% of claims this week
Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Capricor for securities purchased between December 17, 2025 and July 26, 2026.
Newpress release dated Sept 23, 2026
More negative than 71% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit following a 64% stock price drop and FDA briefing documents alleging issues with its statistical analysis plan.
More negative than 86% of ticker scores this week
The company is the subject of a securities class action lawsuit announced by Kaplan Fox.
More negative than 86% of ticker scores this week
The company is the subject of a securities class action lawsuit announced by Kaplan Fox.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
3h ago
−5.4%
Price agrees with the score
$8.84 vs $9.34 close before publication (Sep 22) · not market-adjusted
CAPR chart →
